Kiromic Biopharmaincis A Clinical Stage Immuno Oncology Company Based In Houstontexasfounded In 2006The Company Focuses On Developing Precision Immunotherapies For Cancer Treatmentspecifically Through Ai Drivencrispr Engineered Natural Killernkcell Therapieskiromic Aims To Target Solid Tumors And Hematologic Malignancies With Its Innovative Approaches The Company Offers Advanced Nk Cell Therapiesincluding Krbp 007Which Targets Solid Tumors Like Lung And Ovarian Cancersand Krbp 020A Precision Immunotherapy Platform For Hematologic Malignancieskiromic Utilizes Proprietary Technologies Such As Ai Enhanced Crispr To Optimize Nk Cell Engineering And Improve Therapeutic Outcomeswith A Dedicated Team Of 32 To 43 Employeeskiromic Is Committed To Advancing Its Research And Development Efforts In The Field Of Cancer Treatment
No conferences found for this company.
| Company Name | Kiromic Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
